What was measured: CHD005: The percentage of patients with coronary heart disease with a record in the preceding 12 months that aspirin, an alternative anti-platelet therapy, or an anti-coagulant is being taken.
Data collection end: March 2016
Data collection end: March 2017
||Health and Social Care Information Centre. Quality and Outcomes Framework.